eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
7/2007
vol. 11
 
Share:
Share:
abstract:

The role of angiopoietins 1 and 2 in the regulation of tumor angiogenesis

Ewa Kopczyńska
,
Roman Makarewicz
,
Tomasz Tyrakowski

Współczesna Onkologia (2007) vol. 11; 7 (350–354)
Online publish date: 2007/10/02
View full text Get citation
 
Angiopoietins, besides growth factors, proteolytic enzymes and adhesive molecules, participate in angiogenesis, and also tumours. Angiopoietins 1 and 2 are ligands of the receptor tyrosine kinase Tie-2, specific for endothelial cells. The carboxy-terminal domain is responsible for receptor binding, while the amino-terminal domain enables multimerization of them, necessary for receptor activation. Angiopoietins 1 and 2 have similar ability to bind to receptor Tie-2, whereas Ang-1 is an agonist, and Ang-2 is an antagonist. Ang-1 activates the receptor by induction of tyrosine phosphorylation; protein kinases take part in signal cell transduction. However, Ang-2 inhibits this pathway. The functions of Ang-1 and Ang-2 in angiogenesis in principle are opposite. Ang-1 is responsible for vascular integrity, through stimulation of endothelial cell migration and adhesion, and inhibition of apoptosis. The activity of Ang-2 depends on circumstances; in the absence of VEGF it leads to vascular regression, but in the presence of high VEGF concentration it stimulates angiogenesis. The rapid tumour cell proliferation causes local hypoxia. Hypoxia-inducible factor (HIF-1a) stimulates synthesis of angiopoietins, especially Ang-2. Undoubtedly angiopoietins participate in regulation of tumour angiogenesis, but results of studies carried out so far, both experimental and clinical, are unclear or contradictory.
keywords:

angiopoietins, tumour angiogenesis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.